Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Cranfield University's new sensor detects lung cancer biomarkers quickly, supporting precision medicine and improving early ...

On World Cancer Day, it is essential to spread awareness about how emerging technologies are transforming cancer care and the ...

There are different stages of NSCLC, ranging from 0 to 4; higher-numbered stages indicate the cancer has spread further and tumors are larger. Symptoms and treatment options depend on the stage of ...

WATCH: Princess Kate visits hospital where she received cancer treatment Kate said she remains "focussed on recovery" and added: "As anyone who has experienced a cancer diagnosis will know ...

the trial will study the therapy in patients with Stage 3 unresectable non-small cell lung cancer, who are receiving chemoradiation and consolidation immunotherapy with AstraZeneca’s durvalumab ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years. Overall, though, the news ...

However, some of the other treatments assessed in the study may be viable —and even preferable — for certain lung cancer screening environments depending on their size and resources ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...